Niki BioSolutions, Inc. (NIKI) Income from Continuing Operations (2024 - 2025)
Niki BioSolutions' (NIKI) quarterly Income from Continuing Operations came in at 327410.0 in Q4 2025, up 408.13% YoY from 64434.26 in Q4 2024, and up 144.4% on a QoQ basis from 737365.0 in Q3 2025.
Niki BioSolutions, Inc. (NIKI) Income from Continuing Operations (2024 - 2025) Analysis & Trends
Niki BioSolutions (NIKI) has 2 years of Income from Continuing Operations data on file, last reported at 327410.0 in Q4 2025.
- Quarterly Income from Continuing Operations rose 408.13% year-over-year to 327410.0 in Q4 2025, while the trailing twelve-month figure through Nov 2025 was 175618.0 (changed N/A YoY) and the FY2025 annual result came in at 743235.0, down 20.97% from the prior year.
- Income from Continuing Operations rose to 327410.0 in Q4 2025, from 737365.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 340594.0 in Q2 2025 to a low of 737365.0 in Q3 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2025 | 327,410.00 |
| Aug 31, 2025 | -737,365.00 |
| May 31, 2025 | 340,594.00 |
| Nov 30, 2024 | -106,257.00 |
| Aug 31, 2024 | -176,275.00 |